Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
Blood Adv
.
2022 Aug 9;6(15):4501-4505.
doi: 10.1182/bloodadvances.2022007450.
Authors
Samantha A M Tromp
1
2
,
Marijn A Gillissen
3
,
Sophie J Bernelot Moens
3
,
Ester M M van Leeuwen
2
,
Machiel H Jansen
2
,
Lianne Koens
4
,
Caroline E Rutten
3
,
Taco W Kuijpers
1
2
Affiliations
1
Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.
2
Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
3
Department of Hematology, and.
4
Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
PMID:
35588499
PMCID:
PMC9636311
DOI:
10.1182/bloodadvances.2022007450
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Hepatitis A Virus Cellular Receptor 2*
Substances
Hepatitis A Virus Cellular Receptor 2